Literature DB >> 34342749

CCM2-deficient endothelial cells undergo a ROCK-dependent reprogramming into senescence-associated secretory phenotype.

Corinne Albiges-Rizo1, Hans Van Oosterwyck2,3, Eva Faurobert4, Daphné Raphaëlle Vannier1, Apeksha Shapeti2,3, Florent Chuffart1, Emmanuelle Planus1, Sandra Manet1, Paul Rivier1, Olivier Destaing1.   

Abstract

Cerebral cavernous malformation (CCM) is a cerebrovascular disease in which stacks of dilated haemorrhagic capillaries form focally in the brain. Whether and how defective mechanotransduction, cellular mosaicism and inflammation interplay to sustain the progression of CCM disease is unknown. Here, we reveal that CCM1- and CCM2-silenced endothelial cells expanded in vitro enter into senescence-associated secretory phenotype (SASP) that they use to invade the extracellular matrix and attract surrounding wild-type endothelial and immune cells. Further, we demonstrate that this SASP is driven by the cytoskeletal, molecular and transcriptomic disorders provoked by ROCK dysfunctions. By this, we propose that CCM2 and ROCK could be parts of a scaffold controlling senescence, bringing new insights into the emerging field of the control of ageing by cellular mechanics. These in vitro findings reconcile the known dysregulated traits of CCM2-deficient endothelial cells into a unique endothelial fate. Based on these in vitro results, we propose that a SASP could link the increased ROCK-dependent cell contractility in CCM2-deficient endothelial cells with microenvironment remodelling and long-range chemo-attraction of endothelial and immune cells.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Cerebral cavernous malformations; Mechanotransduction; Microenvironment remodeling; ROCK; Senescence associated secretory phenotype

Mesh:

Substances:

Year:  2021        PMID: 34342749     DOI: 10.1007/s10456-021-09809-2

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  69 in total

Review 1.  Cavernous angiomas: deconstructing a neurosurgical disease.

Authors:  Issam A Awad; Sean P Polster
Journal:  J Neurosurg       Date:  2019-07-01       Impact factor: 5.115

2.  CCM3 Mutations Are Associated with Early-Onset Cerebral Hemorrhage and Multiple Meningiomas.

Authors:  F Riant; F Bergametti; H-D Fournier; F Chapon; S Michalak-Provost; M Cecillon; P Lejeune; H Hosseini; C Choe; M Orth; C Bernreuther; G Boulday; C Denier; P Labauge; E Tournier-Lasserve
Journal:  Mol Syndromol       Date:  2013-04-03

3.  The natural history of familial cerebral cavernomas: a retrospective MRI study of 40 patients.

Authors:  P Labauge; L Brunereau; C Lévy; S Laberge; J P Houtteville
Journal:  Neuroradiology       Date:  2000-05       Impact factor: 2.804

4.  Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations.

Authors:  R E Clatterbuck; C G Eberhart; B J Crain; D Rigamonti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

Review 5.  Genetics of cavernous angiomas.

Authors:  Pierre Labauge; Christian Denier; Francoise Bergametti; Elisabeth Tournier-Lasserve
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182

6.  A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.

Authors:  David A McDonald; Robert Shenkar; Changbin Shi; Rebecca A Stockton; Amy L Akers; Melanie H Kucherlapati; Raju Kucherlapati; James Brainer; Mark H Ginsberg; Issam A Awad; Douglas A Marchuk
Journal:  Hum Mol Genet       Date:  2010-10-11       Impact factor: 6.150

7.  Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells.

Authors:  Matthew R Detter; Daniel A Snellings; Douglas A Marchuk
Journal:  Circ Res       Date:  2018-10-26       Impact factor: 17.367

8.  Postzygotic mosaicism in cerebral cavernous malformation.

Authors:  Matthias Rath; Axel Pagenstecher; Alexander Hoischen; Ute Felbor
Journal:  J Med Genet       Date:  2019-08-24       Impact factor: 6.318

9.  A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.

Authors:  Axel Pagenstecher; Sonja Stahl; Ulrich Sure; Ute Felbor
Journal:  Hum Mol Genet       Date:  2008-12-16       Impact factor: 6.150

10.  Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations.

Authors:  Robert Shenkar; Changbin Shi; Douglas A Marchuk; Issam A Awad; Tania Rebeiz; Rebecca A Stockton; David A McDonald; Abdul Ghani Mikati; Lingjiao Zhang; Cecilia Austin; Amy L Akers; Carol J Gallione; Autumn Rorrer; Murat Gunel; Wang Min; Jorge Marcondes De Souza; Connie Lee
Journal:  Genet Med       Date:  2014-08-14       Impact factor: 8.822

View more
  2 in total

Review 1.  Cerebral Microvascular Senescence and Inflammation in Diabetes.

Authors:  Ashley Phoenix; Raghavendar Chandran; Adviye Ergul
Journal:  Front Physiol       Date:  2022-04-29       Impact factor: 4.755

Review 2.  Cerebral Cavernous Malformation: Immune and Inflammatory Perspectives.

Authors:  Tianqi Tu; Zhenghong Peng; Jian Ren; Hongqi Zhang
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.